Q-omics provides the consensus-scored MYCLP2 profile across patient tissues and cancer cell-line models. MYCLP2 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in THCA. Additionally, MYCLP2 RNA expression shows 6,134 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight THCA, and STAD as cancer lineages where MYCLP2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MYCLP2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MYCLP2 survival associations across molecular data types. MYCLP2 RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MYCLP2 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	8	THCA (36)	view →

This table ranks reproducible MYCLP2 RNA expression–survival associations across cancer types. High MYCLP2 expression shows unfavorable associations in THCA, PAAD, BRCA, STAD and COAD, but favorable associations in SKCM. The THCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .006). Together, the overview and detailed table identify THCA as the clearest survival context for MYCLP2 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	III,IV	0.486	0.868	.006	36	view →
PAAD	OS	Tertile	II,III,IV	0.146	0.557	<.001	36	view →
BRCA	OS	Tertile	II,III,IV	0.842	0.960	.006	33	view →
SKCM	OS	Tertile	All	1.000	0.760	.015	21	view →
STAD	DFS	Tertile	IV	0.254	0.522	.029	18	view →
COAD	OS	Tertile	II,III,IV	0.199	0.660	.013	9	view →

Pink = unfavorable, green = favorable. all 8 lineages →

MYCLP2-THCA (DFS)

Kaplan–Meier survival curve for MYCLP2 RNA expression in THCA: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MYCLP2 in patient tissues and cancer cell lines. In patient samples, MYCLP2 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,134	STAD (5729)	view →
RNA	1,892	SKCM (585)	view →